Brian Nowosielski

The model is designed to increase access, utilization, and adherence to insulin by lowering its maximum price.

Pooja Babbrah, executive vice president of strategy and industry alignment at NCPDP, joined Drug Topics to discuss the power of pharmacy standards in helping patients, pharmacists, and more.

Along with the Senior Care Pharmacy Coalition, 3 additional long-term care advocacy groups have joined in on calls to pass the Preserving Patient Access to Long-Term Care Pharmacies Act.

Through her work as senior vice president of payor solutions at Prescryptive Health, Rae McMahan shares insights into how increased GLP-1 popularity and costs impact pharmacies.

As their scope of practice continues to expand, researchers issue a survey on how community pharmacists conduct point-of-care testing for acute upper respiratory tract infections.

Rae McMahan, senior vice president of payor solutions at Prescryptive Health, discusses GLP-1 access, advertising, and the challenges that often accompany this drug class.

The clinical impact of sodium-glucose cotransporter 2 inhibitors on adults with type 2 diabetes calls for further research on the risk factors of treatment failure and patients’ economic outcomes.

Athena Rae Roesler, MPH, and Anna Lin-Schweitzer, MPH, from the Milken Institute, discuss pharmacists’ role as essential care partners that improve a variety of health concerns for their community’s patients.

Saeed Aboelzahab, director of consumer health at Cardinal Health, discusses the opportunities for community pharmacies to grow revenue through Medicare Advantage OTC benefits.

Chris Bell, JD, vice president of business operations at API Warehouse, discusses proactive approaches in preventing fraudulent threats and staying compliant with DSCSA.

This year’s event, from October 18-21, 2025, will take place in New Orleans, Louisiana, at the Ernest N. Morial Convention Center.

While experts agree there is no one-size-fits-all approach, addressing medication nonadherence among patients presents opportunities for pharmacists to set themselves apart as medication counselors.

In an exploration of cardiovascular outcomes, health care utilization, and patient costs, researchers compare glucagon-like peptide-1s with alternative noninsulin glucose-lowering therapies.

This episode explores how recent trends in the retail community pharmacy industry are informing the actions of pharmacy leadership and their teams across the country.

In part 3 of our interview with Andrew Maiorini, PharmD, FAHM, vice president of clinical programs at PerformRx, he discusses the ways in which his company is helping patients stay adherent on their medications.

Calvin Hunsicker, founder & chief product officer at SureCost, discusses ongoing pharmacy procurement challenges in 2025 and how his company is helping businesses tackle common obstacles.

Among adults with type 1 diabetes, researchers explore how additional autoimmune diseases impacted patients’ physical and mental health burdens.

In a world of decreasing access to medications that are rising dramatically in price, Andrew Maiorini, PharmD, FAHM, reminds us of the power of patient engagement and communication.

Using the Vaccine Adverse Event Reporting System database, researchers address adverse events following pneumococcal vaccination, as well as the association between adverse events and vaccine administration.

Andrew Maiorini, PharmD, FAHM, vice president of clinical programs at PerformRx, discusses the ongoing issue of medication nonadherence and the pharmacists’ crucial role in managing it.

Researchers aim to understand patients’ perception of whether or not they have sufficient information on contraceptives.

Abortion clinic closures impact reproductive health access, prompting a shift toward pharmacists for contraceptive care and highlighting urgent public health needs.

The panel discussion features pharmacy leaders, policy experts, and well-known legal minds discussing the Most Favored Nation drug policy and its overarching implications.

While the new guidelines are reserved for critical care pharmacists in the ICU, they can be applied to other practice areas, highlighting the crucial role pharmacists play in health care.

Due to an increased risk of vaccine-preventable diseases, researchers explore pneumococcal, COVID-19, and influenza vaccine coverage among people living with HIV in Belgium.

Researchers conduct a proof-of-concept study exploring the feasibility of health information technology interoperability between a medical office and independent pharmacies.

Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, led a 21-member panel on critical care pharmacists and joined us to discuss how guideline updates may impact the greater pharmacy industry.

In hospitalized patients with obesity, researchers conduct a study detailing how electronic clinical support helps participants optimize their treatment regimens.

Along with additional bills to further bolster PBM reform, the organizations are aiming to pass the PBM Reform Act for improved medication costs and community pharmacy sustainability.

Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, chair of the committee presenting new guidelines, discussed her role in bolstering pharmacists’ support in the ICU.